Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With GERD

Inclusion Criteria: * Provision of informed consent * Ability to complete PRO instruments (non-applicable to "non-attendees") * Subject with GERD symptom(s). At least presence of troublesome heartburn and/or regurgitation even if not specifically recorded at the Index Visit. * At least one visit during the Retrospective Visit Period (-6 to -2 months prior to study start). In the reasons for the Index Visit section of the medical record mention of acid regurgitation and/or heartburn symptom(s) or GERD diagnosis or GERD complications has to be explicit or a treatment decision (prescription) in a previously diagnosed subject although no mention of symptoms is made. Exclusion Criteria: * Prophylactic PPI use to reduce the risk of ulcers in subjects being treated with NSAIDs * PPI treatment to heal an ulcer induced by NSAID treatment * PPI treatment for H-pylori eradication * Participation in any other clinical study in the time window between the Index Visit and Visit 1